ArticleJournal for immunotherapy of cancer2023

A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma.

Christopher Cultrara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.